Sajazir

— THERAPEUTIC CATEGORIES —
  • Hereditary angioedema

Sajazir Generic Name & Formulations

General Description

Icatibant 10mg/mL; soln for SC inj; preservative-free.

Pharmacological Class

Bradykinin B2 receptor antagonist.

How Supplied

Single-dose prefilled syringe (3mL)—1, 3

Manufacturer

Generic Availability

NO

Sajazir Indications

Indications

For acute attacks of hereditary angioedema (HAE).

Sajazir Dosage and Administration

Adult

≥18yrs: 30mg SC in abdominal area; may give additional doses at intervals of at least 6hrs if response is inadequate or symptoms recur. Max 3 doses/24hrs.

Children

<18yrs: not established.

Sajazir Contraindications

Not Applicable

Sajazir Boxed Warnings

Not Applicable

Sajazir Warnings/Precautions

Warnings/Precautions

Advise patients to seek medical attention after treating laryngeal attack given the potential for airway obstruction. Elderly. Pregnancy. Nursing mothers.

Sajazir Pharmacokinetics

Metabolism

Proteolytic enzymes.

Elimination

Renal.

Sajazir Interactions

Interactions

May attenuate the antihypertensive effect of ACE inhibitors.

Sajazir Adverse Reactions

Adverse Reactions

Inj site reactions, pyrexia, transaminase increase, dizziness, rash.

Sajazir Clinical Trials

See Literature

Sajazir Note

Not Applicable

Sajazir Patient Counseling

See Literature